The regulatory file for borage oil
A borage oil regulatory file ties the specification to the destination where the finished product is sold. It carries the species and grade, the GLA figure and its basis, the contaminant results, the pyrrolizidine-alkaloid statement, the allergen and origin records and the label review. The borage-specific item is the alkaloid file; the refined-oil items are the process contaminants. The buyer's regulatory team confirms the route, because the finished product, the dose and the local rules decide it.
A borage oil file has to prove the species, the alkaloid load and the label name as well as the GLA figure, and the buyer's regulatory team confirms the route for the destination.
What the file has to answer
Start with identity and grade: which species, which process and which version of the specification? Then tie the paperwork to one batch: which lot does the certificate cover, and what were its results? Next, test the destination: does the intended use and daily intake fit the local route and limits? Finally, plan for change: a new seed source, refiner or pack can reopen the file.
Each document answers only part of that. A certificate speaks for one lot; a data sheet describes the material in general; neither decides the market route. The label review, the intake calculation and the novel-food or dietary-ingredient check are separate tasks, and the file should carry them with dates and version numbers.
European Union
Three EU instruments anchor the review: Regulation (EC) No 178/2002 for general food law, Regulation (EU) No 1169/2011 for consumer information, and Regulation (EU) 2023/915 for contaminant limits in force at the time of writing. Borage seed oil has a history of food use in the Union before 15 May 1997, which is the starting point for the novel-food question under Regulation (EU) 2015/2283; the buyer should still check the current catalogue and the process behind the oil, because a new extraction step can change the answer.
Borage is a pyrrolizidine-alkaloid-relevant botanical, and that is the line a generic seed-oil file often misses. The EU contaminant regulation sets a maximum for the sum of a defined list of alkaloids in food supplements, 400 µg/kg at this review, and the limit is assessed on the finished product. The oil result has to be converted to the dose: a lot at the limit can pass at a low inclusion and fail at a high one. Ask for the sum, the individual analytes and the limit of quantification, by LC-MS/MS.
Refined borage oil also brings the process contaminants into scope. 3-MCPD and its fatty acid esters, and glycidyl fatty acid esters, form during deodorisation, and the refinery should state the deodorisation route and provide results when the destination sets a level. A cold-pressed oil has a different process profile but still needs the pesticide, PAH and alkaloid statements that the market requires. In Great Britain the retained framework applies; Northern Ireland follows the EU rules, so the two do not share one file.
United States
In the United States, borage oil is sold as a dietary ingredient, and the file turns on the basis the supplier relies on. The supplier should state that basis and supply the document behind it — a history of use before 15 October 1994 or a notification — and the buyer checks that it reaches the finished product. Reviewers normally work from three sources: the Federal Food, Drug, and Cosmetic Act; the labelling rules in 21 CFR 101; and, for supplements, the cGMPs in 21 CFR 111.
The Supplement Facts panel declares the dietary ingredient by name. “Borage oil” or “Borago officinalis seed oil” is the ingredient; a blend is declared as a blend, with components listed in descending order by weight. A structure or function statement needs the DSHEA disclaimer and must not be a disease claim. The US file does not replace the EU or UK file, and a claim acceptable in one market is not automatically acceptable in another.
Limits and the dose calculation
| Parameter | Release target | What the file must show |
|---|---|---|
| Lead (Pb) | ≤3 mg/kg | Measured value, method and intake arithmetic |
| Arsenic (As) | ≤2 mg/kg | Lot value against the agreed target |
| Cadmium (Cd) | ≤1 mg/kg | Measured value; category exceptions noted |
| Mercury (Hg) | ≤0.1 mg/kg | Measured value with the method |
| Pyrrolizidine alkaloids | Destination limit | Sum, analyte list and LOQ by LC-MS/MS |
| 3-MCPD and glycidyl esters | Destination limit | Refining record plus results where a limit applies |
| Free fatty acid and peroxide value | ≤0.50% and ≤5.0 meq O₂/kg | Lot values and storage record |
| Pesticides and PAH | Destination list | Current-list statement and results |
The catalog limits are the release gates for the oil, not the compliance answer. Each result has to be converted to the daily intake of the finished product and compared with the destination rule. A heavy-metal panel catches neither the alkaloid nor the process-contaminant question, and a PA statement does not cover heavy metals. The file needs both, and the calculation needs the inclusion rate, not only the oil result.
Label and claims
The label has to name the oil. “Borage oil” and “Borago officinalis seed oil” are the food and INCI names, and evening primrose oil is a different ingredient, not a synonym. If the product is a blend, the ingredients are declared in descending order by weight, and the GLA figure needs a basis: per serving, from the oil, with the oil weight stated. A GLA figure is a composition statement; it is not a health claim.
As of this review, there is no authorised EU or UK health claim for borage oil or for GLA, and a claim cannot be built by rephrasing a fatty-acid figure. In the US, a structure or function claim is the brand's responsibility, requires the DSHEA disclaimer and must not be a disease claim. No disease-related claim is made on this page, and the regulatory file does not validate a claim.
Documents in the file
- Version-controlled specification with species, grade, GLA range and profile.
- Lot certificate of analysis with methods, results and the PA statement.
- Technical data sheet and safety data sheet.
- Allergen, GMO and country-of-origin statements.
- Pressing or refining record, including the deodorisation step for a refined grade.
- Heavy-metal, pesticide, PAH and process-contaminant statements as required.
- Packaging declaration, lot-code traceability and retained-sample record.
Checklist before the first order
- The species, grade, specification version and GLA basis are fixed in writing.
- COA, TDS, SDS, allergen, GMO and origin records are present and dated.
- The PA result is reported against the destination limit and calculated at the dose.
- The label and claim review is complete for the destination market.
- Each contaminant result has been recalculated at the finished-product inclusion rate.
- Quotation, specification and certificate all cite the same version.
The catalog limits are on the borage oil product page. Market frameworks are summarised in the EU regulatory note, release tests are listed on the COA page, analytical methods are indexed under methods, the alternative source is covered on the evening primrose oil powder page, and release is described on the quality page.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation